Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DAP001550

Drug Information
NamePazopanib HCl
Trade NameVotrient
CompanyGlaxoSmithKline
IndicationRenal cell carcinoma
[ICD9: 189   ICD10: C64]
Approved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
InChI1S/C21H23N7O2S.ClH/c1-13-5-6-15(11-19(13)31(22,29)30)24-21-23-10-
9-20(25-21)27(3)16-7-8-17-14(2)28(4)26-18(17)12-16;/h5-12H,1-4H3,
(H2,22,29,30)(H,23,24,25);1H
InChIKeyMQHIQUBXFFAOMK-UHFFFAOYSA-N
Canonical SMILESCC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N.Cl    
CAS NumberCAS 444731-52-6
SuperDrug ATC IDL01XE11
L01XE11
TargetC-kitInhibitor[1]
C-kitMultitarget[1]
PDGF-RInhibitor[1]
PDGF-RMultitarget[1]
VEGFR-2Inhibitor[1]
VEGFR-2Multitarget[1]
Ref 1Hughes B: 2009 FDA drug approvals. Nat Rev Drug Discov. 2010 Feb;9(2):89-92. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543